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Aspergillosis is one of the most important deep-seated mycoses in the world, and Japan is not 
an exception. The disease is caused by fungi of the genus Aspergillus comprises a wide variety of 
disease forms. The most common forms are allergic chronic pulmonary aspergillosis including 
aspergilloma, and invasive aspergillosis, and bronchopulmonary aspergillosis. Aspergillosis develops 
mainly in individuals who are defective in the defense system, either from disease or from 
immunosuppressive drugs, and is a leading cause of death in patients with acute leukemia and 
hematopoietic stem cell transplantation.  
There are a number of species among aspergilli, and Aspergillus fumigatus has been reported 
to be the one which causes aspergillosis most often in patients with leukemia or who have undergone 
organ/bone marrow transplantation. However, recent studies showed an increase emergence of 
aspergillosis cases caused by non-fumigatus Aspergillus species inherently more resistant to 
antifungal agents in both bone marrow and solid organ transplant recipients. 
Most microorganisms preferably grow in a complex millieu, in the form of structured 
polymicrobial biofilms on both natural and inanimate surfaces. Microorganisms growing together in 
composite biofilms produce an extracellular matrix (ECM) that binds them to one another and to the 
in vitro or in vivo substrate. These biofilms are well protected from hostile environments of the host 
immune system and also resist antimicrobial killing. The transition of a planktonic form of a microbe 
to a biofilm or a sessile structure (surface-attached) is the result of interactions between different 
  
pathogen and host factors. The formation of these microbial biofilms is a prerequisite event towards 
the development of invasive disease and it has been reported that these biofilms are involved in 
about 80% of non-acute infections in humans. However, only recently have studies been initiated to 
investigate the complicated biofilm phenotype during diseases, especially fungal diseases. Among 
studies on fungal biofilms, biofilms formed by Candida albicans on catheter material and human 
cell surfaces are the most well-studied fungal systems. In contrast the formation of biofilms by 
another opportunistic fungus, A. fumigatus has just begun to be understood. Although the biofilm is 
believed to play a pivotal role in the infection, the major players and molecular mechanisms 
underlying biofilm formation in A. fumigatus-mediated diseases remain largely elusive. 
Previously we have disclosed that serum, as well as serum glycoprotein fetuin A, promotes 
both hyphal growth and biofilm formation of A. fumigatus. However, the detail of biofilm formation 
by Aspergillus spp., particularly by non-fumigatus Aspergillus spp. and the effect of serum on these 
fungi, have been left unattended thus far.  
In my research presented here the biofilm-forming capacity of five representative pathogenic 
Aspergillus spp., i.e., A. fumigatus, A. flavus, A. nidulans, A. niger and A. terreus, was evaluated, and 
the effect of serum/serum proteins, such as fetal bovine serum (FBS), fetuin A and bovine serum 
albumin (BSA), on hyphal growth, hyphal branching and extracellular matrix (ECM) formation.    
In addtion, the antifungal susceptibilities of 171 A. fumigatus isolates, which were collected 
  
from all over the country and stored as A. fumigatus at the Medical Mycology Research Center, 
Chiba University during a recent 22-year period, was determined, when they were not forming 
biofilms and were compared with those forming biofilms. The activity of various antifungal agents 
in combination was also examined to find an optimal method for the treatment of the intractable 
fungal disese with biofilms. 
Fungal growth was promoted by all serum/serum proteins in all species examined, with the 
promotion most evident with FBS, followed by fetuin A and then BSA. The effect was most striking 
in A. fumigatus and least in A. terreus. An analysis with electronmicroscopy showed a thick ECM 
layer surrounding the cell wall when treated with FBS particularly in A. fumigatus. Hyphal 
branching was promoted by fetuin A, which was most evident in A. fumigatus and A. nidulans. When 
antifungal susceptibilities of 171 A. fumigatus isolates were examined, most of them were found to 
be susceptible to antifungal agents when they were not forming biofilms. 
In contrast, biofilm-forming A. fumigatus showed resistance to most antifungal agents, except 
the combination of micafungin and amphotericin B, which suggested synergism. 
My study showed that the serum have substantial effect on biofilm formation and the degree 
of ECM formation varies significantly depending on the Aspergillus species. Since this 
biofilm-forming capacity has been suspected of being an important tool for the persistence of 
infection, my finding is of particular interest from a clinical aspect. Although some other factors 
  
such as gliotoxin production have been proposed as an important virulence factor, no single factor 
has been shown to play a key role in the pathogenesis. As shown in this research, the 
biofilm-forming capacity of A. fumigatus shown here could be another candidate for its virulence 
property, and an analysis of the production of thick ECM and its structure will shed light on the 
development of new therapeutic targets. From the therapeutic point of view, a combination of 
antifungal agents was suggested to carry a potential for the treatment of this intractable biofilm 
disease. 
 
